Workflow
国药集团一致药业股份有限公司 2024年年度权益分派实施公告

Core Viewpoint - The company has approved a profit distribution plan for the fiscal year 2024, which includes a cash dividend of RMB 3.66 per 10 shares, totaling RMB 203.7 million to be distributed to shareholders [1][5][3]. Group 1: Profit Distribution Plan - The profit distribution plan was approved at the annual shareholders' meeting held on June 10, 2025, based on a total share capital of 556,565,077 shares [1][2]. - The total cash dividend to be distributed amounts to RMB 203,702,818.18, with no stock dividends or capital reserve transfers [1][5]. - The cash dividend will be distributed to all shareholders, with specific tax implications based on the type of shares held [5][6]. Group 2: Dividend Payment Details - The cash dividend of RMB 3.66 per 10 shares is inclusive of tax, with different tax treatments for various types of shareholders [5][6]. - The A-share equity registration date is set for June 24, 2025, and the ex-dividend date is June 25, 2025 [7]. - B-share shareholders will have their last trading day on June 24, 2025, with the same ex-dividend date of June 25, 2025 [7][8]. Group 3: Distribution Method - The cash dividends for A-share shareholders will be directly credited to their accounts through their custodial securities companies on June 25, 2025 [9]. - B-share dividends will be credited on June 27, 2025, with specific instructions for shareholders who may need to handle tax-related issues [9][10]. - The company will bear all legal responsibilities for any discrepancies in the dividend distribution process [9].